Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study. (Q54280198)

27 May 2018

title

Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study. (English)

1 reference

27 May 2018

0 references

Zhihong Ma

1

1 reference

27 May 2018

Hongwei Li

2

1 reference

27 May 2018

Bin Wang

3

1 reference

27 May 2018

Qibin Shen

4

1 reference

27 May 2018

Enhai Cui

5

1 reference

27 May 2018

Lishan Min

6

1 reference

27 May 2018

Fuchu Qian

7

1 reference

27 May 2018

Jinliang Ping

8

1 reference

27 May 2018

Licheng Dai

9

1 reference

27 May 2018

publication date

7 December 2012

1 reference

27 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

27 May 2018

volume

139

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

557-562

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-012-1357-1

exact match

0 references

cites work

Increased midkine gene expression in human gastrointestinal cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Midkine is highly expressed in neuroblastoma tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Choice of endogenous control for gene expression in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Expression of midkine and pleiotropin in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Midkine mRNA is overexpressed in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Midkine as a prognostic biomarker in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

Expression of midkine in the early stage of carcinogenesis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1357-1

The revised TNM staging system for lung cancer.

21 January 2018

1 reference

12 December 2020

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE

1 reference

12 December 2020

The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers

1 reference

12 December 2020

Biomarkers in the lung cancer diagnosis: a clinical perspective

1 reference

12 December 2020

Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues

1 reference

12 December 2020

The expression and location of midkine in gastric carcinomas of Chinese patients

1 reference

12 December 2020

10.1007/S00432-012-1357-1

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018